Antimalarial Drugs Market to Witness Robust Growth until 2025
Rising prevalence of malaria
and COVID-19 to drive global antimalarial drugs market
According
to TechSci Research report, “Global
Antimalarial
Drugs Market By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine,
Mefloquine, Hydroxychloroquine, Pyrimethamine, Others), By Drug Class (Aryl
Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds,
Antimicrobials), By Route of Administration (Oral, Powder Inhalation,
Intravenous Administration), By Malaria Type (Plasmodium Falciparum, Plasmodium
Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi), By Application
(Prevention, Treatment of Malaria), By Distribution Channel (Hospital Pharmacy,
Retail Pharmacy, E-Commerce, Others), By Region, Forecast & Opportunities,
2025”, the market is anticipated to
witness robust CAGR during the forecast period. Key factors driving the global antimalarial
drugs market include rising prevalence of malaria, especially in developing
nations and increasing patient deaths from malaria. Also, the exponential
increase in COVID-19 cases around the globe is a major factor fueling the
growth of this market as chloroquines are anticipated to possess the ability to
limit the virus spread. With hydroxychloroquine being a potential treatment for
coronavirus, the market is witnessing a robust demand across various nations.
Moreover, spike in research for new antimalarial drugs are acting augmenting
the market growth. The governments’ focus on the treatment of COVID-19 is
expected to boost the antimalarial drugs market growth through 2025.
Additionally, rise in healthcare expenditure and
availability of wide range of antimalarial drugs are some other key factors
propelling the growth of global antimalarial drugs market. However, the market might
also face some challenges. The side-effects of anti-malarial drugs in many
cases might hamper the market growth. Furthermore, the growing penetration of
counterfeit and substandard drugs are anticipated to restrain the market growth
in the coming years.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on "Global Antimalarial Drugs Market"
https://www.techsciresearch.com/report/antimalarial-drugs-market/5012.html
The global
antimalarial drugs market is segmented based on drug type, drug class, route of
administration, malaria type, application, distribution channel and region.
Based on drug type, the market can be segmented into quinine, chloroquine,
proguanil, amodiaquine, mefloquine, hydroxychloroquine, pyrimethamine and others.
Among them, the hydroxychloroquine drugs are anticipated to register fastest
growth and are expected to dominate the global market through 2025, which can
be attributed to spike in cases of COVID-19 around the world and increasing
usage of hydroxychloroquine for the treatment of virus affected patients.
Based
on malaria type, the global antimalarial drugs market is segmented into plasmodium
falciparum, plasmodium malariae, plasmodium vivax, plasmodium ovale and plasmodium
knowlesi. Among them, the plasmodium falciparum segment is anticipated to dominate
the market during the forecast period as a large part of world population is
heavily exposed to the bites of mosquitoes and is at risk of getting infected
with plasmodium falciparum. Moreover, lack of access to healthcare facilities
and increasing pool of people with low immunity towards malaria is driving the
growth of this segment.
Major players operating in the global antimalarial
drugs market include F. Hoffmann-La Roche Ltd, Alvizia Healthcare Pvt. Ltd.,
Bayer AG, Cipla Limited, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Mayne
Pharma Group Limited, Merck & Co., Inc, , King Pharmaceuticals, Inc,
Novartis AG, Zydus Cadila, Sanofi S.A., Pfizer Inc., Sun Pharmaceutical
Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited,
Glenmark Pharmaceuticals and Lincoln Pharmaceuticals. The manufacturers are
focusing on new product launches, partnerships and acquisitions to strengthen
their position in global antimalarial drugs market.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5012
Customers can also request for
10% free customization on this report.
“India
is one of the leading countries which has a strong presence of pharmaceutical
companies manufacturing hydroxychloroquine. Countries reeling under COVID-19
cases are demanding hydroxychloroquine from India, thereby pushing Indian
government to increase the exports of antimalarial drugs. Manufacturers are increasing
their production capacities and are already producing over 1.5 million tablets
on a daily basis,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Global Antimalarial Drugs Market By Drug Type
(Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine,
Pyrimethamine, Others), By Drug Class (Aryl Aminoalcohol Compounds, Antifolate
Compounds, Artemisinin Compounds, Antimicrobials), By Route of Administration
(Oral, Powder Inhalation, Intravenous Administration), By Malaria Type
(Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium
Ovale, Plasmodium Knowlesi), By Application (Prevention, Treatment of Malaria),
By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce,
Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global antimalarial
drugs market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global antimalarial drugs market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]